Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Kansas Medical Center
About this trial
The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to:
1. show that intravenous lidocaine infusion causes a clinically significant reduction in pain scores in patients with moderate/severe headache pain following non-traumatic subarachnoid hemorrhage; 2. show that intravenous lidocaine infusion is safe in treating headache following non-traumatic subarachnoid hemorrhage; 3. and report vasospasm prevalence in the cohort.
Participants will receive lidocaine infusion as treatment for non-traumatic subarachnoid hemorrhage headache and provide pain scores (on a numeric pain scale) every two hours the patients are awake for a maximum of seven days. Monitoring for vasospasm will occur as part of the patients regular medical care.
Eligibility criteria
Qualifiers
Patients > 18 years;
Have a favorable neurological status defined as Hunt and Hess score ≤ 3 (as it accounts for patient awareness);
Can communicate numeric pain scores;
Are diagnosed with non-traumatic subarachnoid hemorrhage
Disqualifiers
The patient is diagnosed with traumatic subarachnoid hemorrhage;
If the patient is < 18 years of age;
If numeric pain scores could not be captured for > 3 days of hospitalization;
If the patient had a prior aneurysm;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
20 Participants
are grouped into 1 trial groupSponsors and collaborators
University of Kansas Medical Center
Lead sponsor
Ascension Health
Collaborator
Source ClinicalTrials.gov